NCT07065929 Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke
| NCT ID | NCT07065929 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Angers |
| Condition | Acute Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,084 participants |
| Start Date | 2025-09-19 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,084 participants in total. It began in 2025-09-19 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluate the impact of early personalized nutritional management on 1-month mortality after acute stroke. In the randomised centres of the interventional group (early personalized nutritional management), each patient will be assessed by a dietician within 2 days of stroke. Any swallowing problems are screened, and any barriers to eating are identified before dietary support. Patient's food intakes are recorded until the 7th day post-acute to assess their energy intake. Depending on patient's nutritional objectives, a reinforced feeding strategy comprising 2 levels is put in place, in order to prevent malnutrition: in level 1, the dietician tries to meet nutritional requirements orally, while in level 2 he can recourse to artificial nutrition in the event of failure or inability to meet requirements with oral intake alone. This strategy is started immediately after the initial assessment. Intakes are reassessed every 24 to 48 hours by the dietician in order to adapt the nutritional strategy as quickly as possible in order to cover the patient's personnalized nutritional needs. No change in practice was required of the randomised centres in the control group. All patients will be contacted by telephone 30 days after stroke to collect parts of the assessment criteria, while the other criteria will be collected directly from the patient's computerised medical record. Three months after stroke, an evaluation of quality of life and modified Rankin test will be performed. Our hypothesis is that the implementation of an individualized management of early nutritional support, aimed at compensating for the decrease in intake associated with the disease, would reduce mortality at 30 days in patients hospitalised for stroke.
Eligibility Criteria
Inclusion Criteria : * Patients ≥ 18 years of age * With an acute, ischaemic or haemorrhagic outpatient or inpatient stroke * NIHSS score ≥ 5 * Hospitalised in a neurology department, or Neuro Vascular Unit (NVU), or in a department where beds are dedicated to receiving post-stroke patients * Stroke less than 2 days old * Anticipated length of hospital stay in a participating centre ≥ 5 days * Patient affiliated to or benefiting from a social security scheme * Patient or close relative having given written consent to participate in the study or patient included under the emergency procedure in the absence of contactable relatives or patients enrolled under the emergency protocol when no family members were present within 2 days of the stroke. Exclusion Criteria: * Patients treated with nutritional therapy at the time of admission (history of bariatric surgery or gastrectomy, malabsorptive pathologies such as short bowel, extensive intestinal resections, etc.). * In a palliative situation where life expectancy is \< 3 months * Patient taking part in another study with an impact on mortality or nutrition * Previous inclusion in the trial * Pregnant, breast-feeding or parturient woman * Patient unable to follow the protocol for any reason * Patient deprived of liberty by judicial or administrative decision * Patient under compulsory psychiatric care * Person under legal protection * Poor understanding of the French language
Contact & Investigator
Angélique CAMPION
PRINCIPAL INVESTIGATOR
University Hospital, Angers
Frequently Asked Questions
Who can join the NCT07065929 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07065929 currently recruiting?
Yes, NCT07065929 is actively recruiting participants. Contact the research team at Angelique.Campion@chu-angers.fr for enrollment information.
Where is the NCT07065929 trial being conducted?
This trial is being conducted at Chesnay, France, Angers, France, Caen, France, Cholet, France and 8 additional locations.
Who is sponsoring the NCT07065929 clinical trial?
NCT07065929 is sponsored by University Hospital, Angers. The principal investigator is Angélique CAMPION at University Hospital, Angers. The trial plans to enroll 3,084 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.